Today: 29 April 2026
Browse Category

EPA:ABVX.PA 10 December 2025 - 12 January 2026

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax stock slides 9% after Sofinnova flags $134m sale plan, with 2026 trial clock ticking

Abivax shares fell 9.49% to 99.20 euros in Paris on Thursday, reversing a 6% gain from the previous day. Volume reached about 246,000 shares amid anticipation of Phase 3 trial results for obefazimod in late Q2 2026. A U.S. Form 144 filing showed Sofinnova Crossover I SLP intends to sell up to 1,000,000 ADS. BTIG raised its price target on Abivax to $150 and maintained a “Buy” rating.
8 January 2026
·
Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax (ABVX) Stock Jumps on Eli Lilly Takeover Rumors: Latest News, Outlook and Forecasts – December 10, 2025

Abivax shares surged as much as 20% on December 10, 2025, in Paris trading amid market rumors of a possible takeover bid by Eli Lilly. The stock hit a 52-week high near €126.60, with market value reaching about €9.7 billion. Abivax declined to comment, and no formal offer has been announced. U.S.-listed ADRs also jumped over 11% in pre-market trading.
10 December 2025
····

Stock Market Today

  • Powell Industries Inc (POWL) Stock Price Analysis and Performance Overview
    April 29, 2026, 4:26 PM EDT. Powell Industries Inc (POWL) stock performance data shows cumulative returns over various multi-year periods ending March 2021. Returns span one to four years depending on the starting point between 2017 and 2020. The data highlights that past performance does not guarantee future results. Gotrade Securities Inc., licensed under Labuan Financial Services, provides this information as general material without personalized financial advice. Investors should be aware of risks, including potential loss of capital. The content excludes U.S. residents and regions with regulatory restrictions. This reflects typical disclaimers on investment data and the need for caution when interpreting stock returns.

Latest article

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

29 April 2026
Extreme Networks shares surged 28% after reporting fiscal Q3 revenue of $316.9 million, up 11%, and non-GAAP earnings of 26 cents per share, both above estimates. The company forecast Q4 revenue of $330–$335 million, topping FactSet’s $326.9 million estimate. SaaS annual recurring revenue rose 28.6% to $236.4 million. Net income climbed to $10.6 million from $3.5 million a year earlier.
Dow Drops as Fed Split and Oil Surge Put Big Tech’s $10 Trillion AI Test on the Line

Dow Drops as Fed Split and Oil Surge Put Big Tech’s $10 Trillion AI Test on the Line

29 April 2026
Wall Street’s April rally paused Wednesday as the Fed held rates steady in a split decision and oil surged, with Brent crude up 7.34%. The Dow fell 0.56%, S&P 500 slipped 0.04%, and Nasdaq edged up 0.05%. The Fed’s vote was its most divided since 1992, with eight officials backing the hold and one calling for an immediate cut. Investors awaited earnings from Microsoft, Alphabet, Amazon, and Meta.
Amazon Earnings Beat Estimates as AWS AI Growth Hits 15-Quarter High

Amazon Earnings Beat Estimates as AWS AI Growth Hits 15-Quarter High

29 April 2026
Amazon reported first-quarter revenue of $181.5 billion, up 17%, with Amazon Web Services sales jumping 28% to $37.6 billion. Net income reached $30.3 billion, boosted by a $16.8 billion pre-tax gain from Anthropic investments. Free cash flow fell to $1.2 billion as AI-related spending surged. Amazon forecast second-quarter sales of $194 billion to $199 billion, above Wall Street expectations.
Go toTop